A B S T R A C T The most common form of fl-thalassemia among Mediterraneans results from a single nucleotide substitution within the first intervening sequence (IVS-1) of the f-globin gene. This particular mutation is not detectable in uncloned DNA by restriction enzyme analysis. Using synthetic DNA of 19-nucleotides in length corresponding to the normal and mutant IVS-1 sequences as probes, we have developed a direct assay for this gene defect. Under carefully controlled experimental conditions these synthetic probes detect only their homologous sequences in restriction digests of both cloned and uncloned DNA samples. The method is sufficiently sensitive to establish the genotype of individuals with respect to this defect using -20 Ag total DNA. This assay provides an alternative to fetal blood and DNA linkage analysis for the prenatal diagnosis of this variety of fl-thalassemia, particularly among Greek families where it is especially common.
INTRODUCTION
Recombinant DNA methods have permitted characterization of specific mutations in disorders of fl-globin synthesis, the fi-thalassemias (1) . The most common form of fl-thalassemia among Mediterranean patients is due to a single nucleotide change (G -A) in the first intervening sequence (IVS-1)' of the fl-globin gene (2, 3) . This substitution generates a new splicing signal and leads to the formation of abnormally processed RNA that is unstable in vivo (4, 5) . Since some normal messenger (m)RNA is produced as well, albeit in small amounts, this gene has a 8+-thalassemia phenotype (4, 5) . On the basis of gene cloning, DNA sequencing, and examination of linked DNA polymorphisms we estimated that about two-thirds of Greek and one-third of Italian #l-thalassemia genes are of this type (1) . Independent studies by Fukamaki et al. (5) and Ley et al. (6) are consistent with these findings.
As the DNA substitution in this common Oligonucleotide synthesis and labeling. Oligonucleotides were prepared by a solid phase phosphotriester method (12) and labeled at the 5'-end with 32P-'y-ATP (sp act 7,500 Ci/mmol, New England Nuclear, Boston, MA). 50-80 ng of oligonucleotide was incubated in standard kinase buffer (13) plus 100-150 MCi 32P-y-ATP and 5 U polynucleotide kinase (Boehringer Mannheim Biochemicals, Indianapolis, IN) in 10,ul total volume for 1 h at 37°C. Labeled oligonucleotide was separated from unincorporated ATP by passage through Bio-Gel P-4 (Bio-Rad Laboratories, Richmond, CA) in 10 mM Tris-HCl pH 7.5 and 0.1 mM EDTA. The specific activity of the probes used was 7-10 X 108 dpm/Mg. Blot hybridization. DNA samples were digested with the restriction enzyme BamHI (Bethesda Research Laboratories) and electrophoresed in 1% agarose at 1.5 V/cm for 16 h. DNA was blotted onto nitrocellulose filter sheets (Schleicher & Schuell, Inc., Keene, NH) as described by Southern (14) in 6 X SSC (0.9 M NaCi, 0.09 M Na citrate). Following baking at 80'C under vacuum for 2 h, filters were prehybridized in 6 X SSC, five times concentrated Denhardt's solution (0.1% Ficoll, serum albumin, and polyvinylpyrollidone [15] ), 0.5% sodium dodecyl sulfate, 0.05% sodium pyrophosphate, and 100 Mg/ml sonicated and denatured salmon sperm DNA at 650C for at least 3 h. Filters were then hybridized with labeled oligonucleotide at a concentration of 5 ng/ml in 6 X SSC, two times concentrated Denhardt's solution (0.04% Ficoll, serum albumin, and polyvinylpyrollidone), (100 ,g/ ml yeast transfer (t)RNA, 100 Ag/ml salmon sperm DNA, 0.05% sodium pyrophosphate for 36-48 h at 41'C. Filters were rinsed in 500 ml 6 X SSC plus 0.05% sodium pyrophosphate at room temperature, 370, and 41'C for at least 30 min each. Final washing consisted of a 3-min incubation at 470 and 490C for filters hybridized with the mutant and normal probes, respectively. Filters were exposed to x-ray film at -70'C with a lightening plus intensifying screen for 2-7 d.
RESULTS
As probes for the normal f3-globin gene and the common f3-thalassemia gene we prepared two 19 nucleotide long fragments, shown in Fig. 1 . For simplicity, the normal gene probe is referred to as the "G" probe and the f3-thalassemia probe as the "A" probe. Conditions were first established in which the normal and the common f3-thalassemia genes could be distinguished by hybridization with these probes. Plasmid DNA containing these genes were digested with BamHI, electrophoresed in agarose, and blotted onto nitrocellulose filters. Replicate filters were hybridized separately with the oligonucleotide probes. Results are shown in Fig. 2 (10 Aig per lane and two probes). Less DNA might suffice using much longer autoradiographic exposures, but this would not be practical for diagnostic purposes. DISCUSSION Synthetic oligonucleotides can be used as highly specific molecular hybridization probes (7, 8) . Using probes prepared for the region of the fl-globin gene mutated in the most common form of fl-thalassemia seen among Mediterraneans we have established that definitive genotype assignments can be made by hybridization of uncloned DNA under carefully controlled experimental condition. Therefore, this and other forms of fl-thalassemia associated with no alterations in restriction enzyme sites in the (3-gene should now be amenable to prenatal diagnosis by direct assay of the primary defect. Our results underscore the general nature of this method of mutant gene detection, originally proposed by Wallace et al. (7) and Conner et al. (8) .
The fl-thalassemia gene that we have studied is of particular importance due to its high prevalence among Mediterranean patients (1, 5, 6) . Among many families of Greek or Italian ancestry the method described here should provide a reasonable alternative to fetal blood assay (16) and DNA linkage analysis (17, 18) for prenatal diagnosis. In practice, examination of parental DNA will be required to establish the type of thalassemia mutation carried by each. This is essential because (3-thalassemia mutations other-than the common variety studied here will appear normal when assessed with the G probe. Accurate genotype assignments depend on hybridization with both normal and mutant oligonucleotides. Sets of oligonucleotide probes for other gene defects already characterized among Mediterraneans (1) and for common mutant genes in other populations would allow widespread application of this strategy.
How practical is this new approach relative to fetal blood sampling for prenatal diagnosis of hemoglobinopathies? Several strengths of this method should be noted. First, it identifies the primary gene mutation, rather than a phenotypic consequence. Second, the method is quite sensitive; -20 ,gg of DNA is required to permit hybridization with both probes. Third, the absence of DNA sequence polymorphism nearby any of the known f3-thalassemia mutations (9) indicates that normal sequence variation will not interfere with this approach. On the other hand, there are two practical drawbacks. First, study of parental DNA is required to permit complete genotyping of the fetus due to genetic heterogeneity. This is necessary because all ,B-thalassemia mutations other than that studied here would be scored as "normal" genes using the G and A oligonucleotides, as their defects reside in other regions of the ,B-globin gene. Second, the requirement for 20 jig DNA necessitates culture of amniotic fluid cells to provide sufficient material for diagnosis. A substantial increase in the specific activity of the probes would circumvent this problem and permit assay of DNA extracted directly from amniotic fluid cells, as can now be performed in the sickle-cell anemia diagnosis (19) (20) (21) . Nevertheless, at present, the method we have described here should be useful in prenatal diagnosis by amniocentesis, particularly among Greek families. Since the frequency of this mutation among Greek f3-thalassemia genes is roughly 67%, nearly half (0.67 X 67) of Greek families would be suitable for complete genotype analysis of this mutation in the fetus. In other families in which this mutant gene was present in only one parent, severe fl-thalassemia could be excluded by demonstrating the absence of this gene in fetal DNA. The availability of sets of oligonucleotides for additional fl-thalassemia mutations will greatly increase the proportion of families suitable for prenatal diagnosis by this approach.
The use of direct detection of ,B-thalassemia mutations by hybridization with synthetic probes is likely to become substantially more attractive as an alternative to midtrimester fetal blood sampling if the safety of first trimester chorionic villi biopsies (22) 
